Woodward Diversified Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Hold
3,744
0.1% 167
2026
Q1
$225K Buy
3,744
+19
+0.5% +$1.11K 0.1% 163
2025
Q4
$201K Buy
+3,725
New +$179K 0.09% 176
2024
Q2
Sell
-4,931
Closed -$267K 161
2024
Q1
$267K Buy
4,931
+647
+15% +$33K 0.17% 133
2023
Q4
$220K Sell
4,284
-525
-11% -$27.6K 0.14% 139
2023
Q3
$279K Sell
4,809
-5,509
-53% -$338K 0.2% 116
2023
Q2
$660K Buy
10,318
+23
+0.2% +$1.54K 0.5% 56
2023
Q1
$714K Buy
10,295
+31
+0.3% +$2.19K 0.56% 50
2022
Q4
$738K Sell
10,264
-571
-5% -$43.1K 0.59% 47
2022
Q3
$770K Sell
10,835
-762
-7% -$55.3K 0.63% 38
2022
Q2
$893K Buy
11,597
+35
+0.3% +$2.67K 0.68% 39
2022
Q1
$844K Sell
11,562
-158
-1% -$10.6K 0.55% 51
2021
Q4
$731K Buy
11,720
+766
+7% +$44.9K 0.43% 60
2021
Q3
$648K Buy
10,954
+2,591
+31% +$171K 0.41% 72
2021
Q2
$559K Buy
8,363
+494
+6% +$32.2K 0.32% 81
2021
Q1
$497K Sell
7,869
-485
-6% -$30.2K 0.29% 90
2020
Q4
$518K Buy
+8,354
New +$514K 0.34% 71

Other funds holding BMY

Woodward Diversified Capital's BMY Position: Q2 2026 in Review

Woodward Diversified Capital held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,744 shares worth $216K. The position accounts for 0.1% of the portfolio, ranked #167.

Woodward Diversified Capital first reported a position in BMY in Q4 2020 and has held it in 17 quarters since. The position peaked at $893K in Q2 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Woodward Diversified Capital held 3,744 shares of Bristol-Myers Squibb worth $216K as of Q2 2026.
  • Woodward Diversified Capital left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.1% of Woodward Diversified Capital's portfolio in Q2 2026, its #167 holding.
  • Woodward Diversified Capital first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 17 quarters since.
  • Woodward Diversified Capital's Bristol-Myers Squibb position peaked at $893K in Q2 2022.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Woodward Diversified Capital's 13F filing for Q2 2026, filed 28 Jul 2026.